Pass the CBIC Infection Control CIC Questions and answers with CertsForce

Laryngeal tuberculosis (TB) is highly contagious because it involves the upper respiratory tract, leading to direct aerosolized transmission of Mycobacterium tuberculosis through talking, coughing, or sneezing.

Why the Other Options Are Incorrect?

A. Renal TB – Genitourinary TB is not typically transmissible via airborne droplets.

B. Miliary TB – While systemic, it does not involve direct respiratory transmission.

D. Tuberculous meningitis – TB in the central nervous system is not spread through respiratory secretions.

CBIC Infection Control Reference

APIC confirms that laryngeal TB is one of the most infectious forms and requires Airborne Precautions

The infection preventionist’s (IP) best conclusion, based on the provided evidence, is that the evidence at this time fails to support the nurse's claim of acquiring hepatitis A virus (HAV) infection through occupational exposure. This conclusion is grounded in the clinical and epidemiological understanding of HAV, as aligned with the Certification Board of Infection Control and Epidemiology (CBIC) guidelines. Hepatitis A typically has an incubation period ranging from 15 to 50 days, with an average of approximately 28-30 days, following exposure to the virus (CBIC Practice Analysis, 2022, Domain I: Identification of Infectious Disease Processes, Competency 1.3 - Apply principles of epidemiology). The reported 5-day interval between exposure and symptom onset in the nurse is significantly shorter than the expected incubation period, making it inconsistent with HAV transmission. Additionally, the presence of immunoglobulin G (IgG) antibodies in the source patient indicates past exposure or immunity to HAV, rather than an active or recent infection, which would typically be associated with immunoglobulin M (IgM) antibodies during the acute phase.

Option A (the nurse should be given hepatitis A virus immunoglobulin) is not supported because post-exposure prophylaxis with HAV immunoglobulin is recommended only within 14 days of exposure to a confirmed case with active infection, and the evidence here does not confirm a recent exposure or active case. Option C (the patient has serologic evidence of recent hepatitis A viral infection) is incorrect because IgG antibodies signify past infection or immunity, not a recent infection, which would require IgM antibodies. Option D (the 5-day incubation period is consistent with hepatitis A virus transmission) is inaccurate due to the mismatch with the known incubation period of HAV.

The IP’s role includes critically evaluating epidemiological data to determine the likelihood of transmission events. The discrepancy in the incubation period and the serologic status of the patient suggest that the nurse’s claim may not be substantiated by the current evidence, necessitating further investigation rather than immediate intervention or acceptance of the claim. This aligns with CBIC’s emphasis on accurate identification and investigation of infectious disease processes (CBIC Practice Analysis, 2022, Domain I: Identification of Infectious Disease Processes, Competency 1.2 - Investigate suspected outbreaks or exposures).

The scenario involves a needlestick injury sustained by a phlebotomist during the resuscitation of a patient diagnosed with Neisseria meningitidis infection, characterized by a petechial rash, meningitis, and cardiac arrest. Neisseria meningitidis is a gram-negative diplococcus that can cause meningococcal disease, including meningitis and septicemia, and is transmitted through direct contact with respiratory secretions or, in rare cases, blood exposure. The exposure management for the phlebotomist must align with infection control guidelines, such as those from the Certification Board of Infection Control and Epidemiology (CBIC) and the CDC, to prevent potential infection. Let’s evaluate each option:

A. Prophylactic rifampin plus isoniazid: Prophylactic antibiotics are recommended for close contacts of individuals with meningococcal disease to prevent secondary cases. Rifampin is a standard prophylactic agent for Neisseria meningitidis exposure, typically administered as a 2-day course (e.g., 600 mg every 12 hours for adults). Isoniazid, however, is used for tuberculosis (TB) prophylaxis and is not indicated for meningococcal disease. Combining rifampin with isoniazid is incorrect, as it reflects a confusion with TB management rather than meningococcal exposure. This option is not appropriate.

B. A tuberculin skin test now and in ten weeks: A tuberculin skin test (TST) or interferon-gamma release assay (IGRA) is used to screen for latent tuberculosis infection, with a follow-up test at 8-10 weeks to detect conversion after potential TB exposure. Neisseria meningitidis is not related to TB, and a needlestick injury from a meningococcal patient does not warrant TB testing. This option is irrelevant to the scenario and not the correct exposure management.

C. Work furlough from day ten to day 21 after exposure: Neisseria meningitidis has an incubation period of 2-10 days, with a maximum of about 14 days in rare cases. The CDC and WHO recommend that healthcare workers exposed to meningococcal disease via needlestick or mucosal exposure be monitored for signs of infection (e.g., fever, rash) and, if symptomatic, isolated and treated. Additionally, a work restriction or furlough from day 10 to day 21 after exposure is advised to cover the potential incubation period, especially if prophylaxis is declined or contraindicated. This allows time to observe for symptoms and prevents transmission to vulnerable patients. This is a standard infection control measure and the most appropriate initial management step pending prophylaxis decision.

D. A review of the phlebotomist’s hepatitis B vaccine status: Reviewing hepatitis B vaccine status is a critical step following a needlestick injury, as hepatitis B can be transmitted through blood exposure. However, this applies to bloodborne pathogens (e.g., HBV, HCV, HIV) and is not specific to Neisseria meningitidis, which is primarily a respiratory or mucosal pathogen. While hepatitis B management (e.g., post-exposure prophylaxis with hepatitis B immunoglobulin or vaccine booster) should be addressed as part of a comprehensive needlestick protocol, it is not the first or most relevant priority for meningococcal exposure.

The best answer is C, as the work furlough from day 10 to day 21 after exposure addresses the specific risk of meningococcal disease following a needlestick injury. This aligns with CBIC’s focus on timely intervention and work restriction to prevent transmission in healthcare settings. Prophylactic antibiotics (e.g., rifampin) should also be considered, but the question asks for the exposure management, and furlough is a primary control measure. Hepatitis B and TB considerations are secondary and managed separately.

CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain III: Prevention and Control of Infectious Diseases, which includes protocols for managing exposure to communicable diseases like meningococcal infection.

CBIC Examination Content Outline, Domain IV: Environment of Care, which addresses work restrictions and exposure management.

CDC Guidelines for Meningococcal Disease Prevention and Control (2023), which recommend work furlough and monitoring for exposed healthcare workers.

The CBIC Certified Infection Control Exam Study Guide (6th edition) clearly states that the correct and recommended method for obtaining urine cultures in patients with an indwelling urinary catheter is to collect the specimen using aseptic technique from the catheter’s designated sampling (collection) port. This method minimizes the risk of contamination and provides the most accurate reflection of organisms present in the urinary tract.

Urine collected from the sampling port is obtained after disinfecting the port and aspirating urine with a sterile syringe. This approach maintains the integrity of the closed drainage system and reduces the introduction of microorganisms. Accurate culture collection is essential for correct diagnosis of catheter-associated urinary tract infection (CAUTI) and for distinguishing true infection from colonization or contamination.

Option B is incorrect because culturing the catheter tip is not recommended for diagnosing CAUTI; it does not reliably represent urinary tract pathogens and may reflect biofilm colonization. Option C is inappropriate because disconnecting the catheter from the drainage tubing breaks the closed system and increases infection risk. Option D is incorrect because urine from the drainage bag is often contaminated and does not accurately represent bladder urine.

For CIC® exam preparation, it is critical to recognize that aseptic aspiration from the catheter sampling port is the standard of care for urine culture collection in catheterized patients and is a core infection prevention principle related to CAUTI surveillance and diagnosis.

==========

An Ishikawa diagram (fishbone diagram) is used to visually represent cause-and-effect relationships in problem analysis. It is best for summarizing and categorizing issues found in a gap analysis related to infection prevention.

The APIC Text confirms:

“A fishbone diagram (also called a tree diagram or Ishikawa) allows a team to identify, explore, and graphically display all of the possible causes related to a problem to discover the root cause”.

It’s particularly useful in quality improvement and infection prevention project analysis.

The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes the importance of traceability in endoscope reprocessing programs to ensure rapid and accurate patient notification when reprocessing failures or recalls occur. The most effective method for identifying affected patients is maintaining a log that directly links each endoscope to specific patient identifiers for every procedure.

This type of tracking system allows infection preventionists to quickly determine exactly which patients were exposed to a particular endoscope during the time period of concern. When reprocessing failures are identified—such as incomplete cleaning, high-level disinfection errors, or equipment malfunction—precise linkage between the endoscope and the patient is essential to limit the scope of exposure investigations, reduce unnecessary notifications, and ensure timely follow-up care.

Option A is insufficient because a date-only log does not identify individual patients. Option C may be useful if serial numbers are consistently documented in the medical record, but this practice is not reliably implemented in many facilities and is therefore less dependable. Option D is overly broad and would identify all patients who underwent endoscopy, rather than those exposed to a specific device, leading to unnecessary alarm and inefficient investigations.

For CIC® exam purposes, understanding that patient-to-device linkage logs are the cornerstone of effective exposure investigation and recall management in endoscope reprocessing is critical and aligns with best-practice infection prevention standards.

HIV post-exposure prophylaxis (PEP) should be initiated within 2 hours to be most effective​.

Waiting for results (B) delays critical treatment.

PEP should always be offered after high-risk exposure, not only if symptoms develop (C).

Retesting after 6 months (D) is recommended but should not delay PEP initiation.

CBIC Infection Control References:

APIC Text, "Bloodborne Pathogens and PEP," Chapter 11​.

Reviewing compliance with VAP prevention bundles (e.g., head-of-bed elevation, oral care, sedation breaks) is the first step in outbreak control​.

Preemptive antibiotics (B) are not recommended due to antibiotic resistance risks.

Negative pressure rooms (C) are not required for VAP.

Ventilator circuit cultures (D) do not guide patient management.

CBIC Infection Control References:

APIC Text, "VAP Prevention Measures," Chapter 11​.

Antibiotic stewardship programs are designed to optimize antimicrobial use, improve patient outcomes, reduce antimicrobial resistance, and decrease unnecessary costs. The CBIC Certified Infection Control Exam Study Guide (6th edition) identifies formulary restriction and preauthorization as key core strategies within effective antimicrobial stewardship programs. A closed formulary specifically refers to a system in which access to certain antibiotics is restricted and requires prior approval before dispensing.

In a closed formulary model, prescribers must obtain authorization—often from infectious diseases specialists, pharmacy, or an antimicrobial stewardship team—before selected antimicrobial agents can be used. This approach ensures that high-risk, broad-spectrum, or high-cost antibiotics are used only when clinically appropriate. By requiring approval, the organization promotes judicious antibiotic selection, prevents unnecessary exposure, and supports resistance prevention efforts.

Option B describes de-escalation, which is another stewardship strategy but does not define a closed formulary. Option C refers to antibiotic cycling, a controversial and less-supported strategy. Option D is incorrect because a closed formulary does not merely limit availability; rather, it controls access through approval mechanisms.

For the CIC® exam, it is critical to distinguish between stewardship strategies. A closed formulary is best characterized by mandatory approval prior to dispensing, making option A the most accurate answer according to the Study Guide’s antimicrobial stewardship framework.

==========

The CBIC Certified Infection Control Exam Study Guide (6th edition) identifies aseptic technique as the most critical factor influencing the growth of microorganisms in multi-dose medication vials. Multi-dose vials are designed for repeated entry and therefore carry an inherent risk of contamination if proper infection prevention practices are not strictly followed.

Microbial growth in a vial most often results from breaks in aseptic technique during medication preparation or access. This includes failure to disinfect the rubber septum with alcohol prior to vial entry, reuse of needles or syringes, use of contaminated hands or gloves, and improper storage after opening. Once microorganisms are introduced into a vial, preservatives may not fully inhibit growth, especially if contamination levels are high or storage conditions are suboptimal.

Syringe size (Option A) does not influence microbial growth. Patient comorbidities (Option C) affect infection risk in the patient but have no impact on contamination within the vial itself. Administration techniques (Option D) relate to how medication is delivered to the patient, not how organisms enter or proliferate within the medication container.

The Study Guide emphasizes that strict adherence to aseptic technique—including hand hygiene, use of sterile needles and syringes, septum disinfection, and proper storage—is essential to prevent contamination of multi-dose vials. Numerous healthcare-associated outbreaks have been traced to failures in these practices.

For the CIC® exam, this question reinforces that aseptic technique is the primary determinant of microbial contamination and growth in medication vials, making it the correct answer.